Clinical Trial

Prospective WCD Post CABG Registry (CABG Registry)

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective is to observe the rate of recovery of ventricular function (EF\>35%) after first-time coronary artery bypass graft surgery in patients who were prescribed the wearable cardioverter defibrillator (WCD) post-surgery prior to being discharged after hospitalization as part of standard clinical care.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-08-22.
Status change: Not Yet Recruiting → Recruiting 2024-10-31
Trial Details
NCT Number NCT06570902
Lead Sponsor Zoll Medical Corporation
Conditions Cardiomyopathy Ischemic, Cardiomyopathies, Cardiovascular Diseases, Heart Disease, Ischemic
Enrollment 910 participants
Start Date 2024-09-23
Primary Completion 2029-11 (estimated)
Study Completion 2030-05 (estimated)
Updated on ClinicalTrials.gov 2024-11-04